Related Experiment Video
Updated: Jun 2, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Molecular targets of selenium in prostate cancer prevention (Review)
Rizky Abdulah1, Kenji Kobayashi, Chiho Yamazaki
1Division of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung Sumedang Km.21, Jatinangor 45363, Indonesia. abdulahrizky@gmail.com
Abstract:
Prostate cancer is one of the leading causes of cancer-related deaths among males. Although use of the micro-nutrient selenium in prostate cancer clinical trials is limited, the outcomes indicate that selenium is a promising treatment. Furthermore, selenium inhibits prostate cancer through multiple mechanisms, and it is beneficial in controlling the development of this disease. This review highlights the latest epidemiological and biomolecular research on selenium in prostate cancer, as well as its prospects for future clinical use.
Insights
Selenium shows promise in treating prostate cancer, inhibiting its development through various mechanisms. Further research supports its potential clinical use for this male cancer.
Area of Science:
- Oncology
- Nutritional Science
- Molecular Biology
Background:
- Prostate cancer is a significant cause of cancer-related mortality in men.
- Clinical applications of the micronutrient selenium for prostate cancer are currently limited.
- Emerging evidence suggests selenium's therapeutic potential in prostate cancer management.
Purpose of the Study:
- To review current epidemiological and biomolecular research on selenium's role in prostate cancer.
- To evaluate the prospects of selenium for future clinical application in prostate cancer treatment.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of biomolecular research on selenium's mechanisms of action.
- Assessment of clinical trial outcomes and future potential.
Main Results:
- Selenium demonstrates inhibitory effects on prostate cancer through multiple biological pathways.
- Existing clinical trial data, though limited, indicates positive outcomes with selenium use.
- Selenium appears beneficial in controlling the progression of prostate cancer.
Conclusions:
- Selenium is a promising micronutrient for prostate cancer intervention.
- Further investigation into selenium's efficacy and safety in clinical settings is warranted.
- Selenium holds potential for integration into future prostate cancer treatment strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Prevention
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

